TESTICULAR CANCER
Clinical trials for TESTICULAR CANCER explained in plain language.
Never miss a new study
Get alerted when new TESTICULAR CANCER trials appear
Sign up with your email to follow new studies for TESTICULAR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug enters first human safety tests
Disease control Recruiting nowThis is a very early-stage study to test the safety of a new drug called GV20-0251 in adults with advanced solid tumors that have progressed despite standard treatments. The main goal is to find a safe dose by giving the drug to small groups of patients at different levels. It is…
Matched conditions: TESTICULAR CANCER
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New combo attack on tough cancers: radiation meets targeted drug
Disease control Recruiting nowThis study is testing whether it is safe to combine a new targeted drug called tarlatamab with standard radiation therapy. It is for adults with advanced cancers that have a specific protein called DLL3, including certain lung cancers, melanoma, and others. The main goal is to se…
Matched conditions: TESTICULAR CANCER
Phase: PHASE1, PHASE2 • Sponsor: University of Arizona • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New cancer drug targets Hard-to-Treat tumors in first human trial
Disease control Recruiting nowThis early-stage trial is testing a new drug called CTIM-76 for people with advanced ovarian, testicular, or endometrial cancers that have stopped responding to standard treatments. The study will enroll 80 participants to determine safe dosage levels and see if the drug helps co…
Matched conditions: TESTICULAR CANCER
Phase: PHASE1 • Sponsor: Context Therapeutics Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New hope for tough cancers: observing a promising Drug's Real-World impact
Disease control Recruiting nowThis study aims to see how well the drug T-DXd works in real-world settings for patients with advanced HER2-positive cancers who have already tried other treatments and have no good options left. It will follow about 100 patients with various solid tumors (excluding breast, lung,…
Matched conditions: TESTICULAR CANCER
Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
Common aspirin may shield cancer patients from deadly clots
Prevention Recruiting nowThis study is testing if a daily low-dose aspirin pill can prevent dangerous blood clots in men with advanced testicular or germ cell cancer who are receiving chemotherapy. The trial will enroll 35 participants at high risk for clots to take aspirin daily for 6 months while under…
Matched conditions: TESTICULAR CANCER
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Prevention
Last updated Apr 01, 2026 14:42 UTC
-
New surgical technique aims to slash pain after testicular cancer surgery
Symptom relief Recruiting nowThis study is comparing two standard surgical techniques for removing a testicle when cancer is suspected. Researchers want to see if a modified technique that spares a specific muscle layer causes less pain after surgery, reduces the need for opioid painkillers, and leads to few…
Matched conditions: TESTICULAR CANCER
Phase: NA • Sponsor: Loma Linda University • Aim: Symptom relief
Last updated Apr 01, 2026 14:40 UTC
-
New app aims to ease pain and anxiety for young cancer survivors
Symptom relief Recruiting nowThis study is testing a digital health program called AYA STEPS that helps young adult cancer survivors manage symptoms like pain, fatigue, and emotional distress. The program teaches skills to improve communication with healthcare providers and engagement with recommended follow…
Matched conditions: TESTICULAR CANCER
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
New study aims to reduce pain medication after cancer surgery
Symptom relief Recruiting nowThis study compares two different pain management approaches for men undergoing surgery for testicular cancer. Researchers want to see which method better controls pain while reducing the amount of opioid medication needed after surgery. The study involves 142 male participants a…
Matched conditions: TESTICULAR CANCER
Phase: PHASE3 • Sponsor: Indiana University • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC
-
AI steps in: can a computer find the right cancer trial for you?
Knowledge-focused Recruiting nowThis study is testing a new artificial intelligence (AI) tool designed to help match people with advanced cancer to suitable clinical trials. It will enroll up to 50,000 patients to see if using this AI system makes it easier for patients to find and join trials. The researchers …
Matched conditions: TESTICULAR CANCER
Sponsor: Massive Bio, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
Massive cancer database seeks volunteers to help unlock disease secrets
Knowledge-focused Recruiting nowThis study is building a large, long-term database of health information and biological samples from people with cancer, people at risk for cancer, and healthy volunteers. The goal is to collect this data to help researchers better understand what causes cancer and how to prevent…
Matched conditions: TESTICULAR CANCER
Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC